| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Tyra Biosciences, Inc.
13G/A
TYRA · 90240B106
|
6.0% |
8/14/2026
Event 6/30/2026
|
||||
| Nextech VI Oncology SCSp | 6.0% | |||||
| Nextech VI GP S.a. r.l. | 6.0% | |||||
| Ian Charoub | 6.0% | |||||
| Costas Constantinides | 6.0% | |||||
| Rocco Sgobbo | 6.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.